Daily ECMO check: could a simple protocol save lives and money?

NCT ID NCT05486559

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a daily, step-by-step assessment could help doctors safely remove patients from a life-support machine called ECMO sooner. 225 adults on ECMO were randomly assigned to either the daily protocol or usual care. The goal was to see if the protocol shortened the time on ECMO without increasing risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
daily assessment protocol for readiness to stop ECMO
What this could lead to
If successful, this protocol could help doctors safely remove patients from ECMO sooner, reducing complications and hospital costs.
What could go wrong
This is a completed trial, but the approach may not work for all patients or hospitals. The study is relatively small (225 people) and focused on one type of ECMO.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTRACORPOREAL MEMBRANE OXYGENATION COMPLICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor University Medical Center

    Dallas, Texas, 75246, United States

  • Hennepin County Medical Center

    Minneapolis, Minnesota, 55415, United States

  • Stanford University

    Stanford, California, 94305, United States

  • Texas Tech University Health Sciences Center of El Paso

    El Paso, Texas, 79905, United States

  • Toronto General Hospital

    Toronto, Ontario, M5G 2C4, Canada

  • UC San Diego Health

    San Diego, California, 92037, United States

  • University of Utah Health

    Salt Lake City, Utah, 84112, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.